Last Updated on July 21, 2026
According to the CDC, about 220,000 children under 18 in the United States have arthritis — a group of autoimmune and inflammatory conditions that cause joint pain, swelling, and stiffness in kids and teens. The good news is that today’s medications can control the disease and protect growing joints. The challenge is juvenile arthritis medication costs: many of the most effective treatments are specialty biologics that can carry very high price tags. This Juvenile Arthritis Awareness Month, we’re highlighting the treatments used and, more importantly, the programs that help families afford them.
Understanding juvenile arthritis
Juvenile arthritis isn’t a single disease — it’s an umbrella term for several conditions, the most common being juvenile idiopathic arthritis (JIA). These are autoimmune conditions, meaning the immune system mistakenly attacks the body’s own joints. Left untreated, the inflammation can interfere with a child’s growth and development, which is why early, consistent treatment matters. Care is usually managed by a pediatric rheumatologist and often combines medication, physical therapy, and regular monitoring.
Common treatments for juvenile arthritis
Treatment is typically layered, starting with the least aggressive option that controls the disease:
NSAIDs and conventional DMARDs. Nonsteroidal anti-inflammatory drugs help with pain and swelling, while conventional disease-modifying antirheumatic drugs (DMARDs) — most commonly methotrexate — work to slow the disease itself. Methotrexate is available in several forms, including Otrexup (a subcutaneous auto-injector).
Biologic DMARDs. When conventional DMARDs aren’t enough, biologics target specific parts of the immune response. Several are used in children and are commonly prescribed for JIA:
- Enbrel (etanercept)
- Humira (adalimumab)
- Orencia (abatacept)
- Actemra (tocilizumab)
- Kineret (anakinra)
Because these are specialty medications, they’re also where cost becomes the biggest barrier — and where the most assistance is available.
How NeedyMeds can help with juvenile arthritis medication costs
Juvenile arthritis medications are backed by manufacturer copay cards, patient assistance programs, and diagnosis-based funds. Patient assistance programs and diagnosis-based funds each have their own pages you can open directly. Copay cards work differently — they’re shown within each medication’s page — so throughout this section, click a medication name to see its specific copay-card details.
If you have commercial insurance: manufacturer copay cards
For families with commercial (non-government) insurance, manufacturer savings cards can bring out-of-pocket costs down dramatically — in many cases to as little as $0 per dose or per month. Click a medication to see its current card details:
- Enbrel — the Enbrel Co-pay Program lets eligible commercially insured patients pay as little as $0 per dose.
- Humira — the Humira Complete Savings Card lets eligible commercially insured patients pay as little as $0 per monthly prescription.
- Orencia — the Orencia On Call co-pay card lets eligible commercially insured patients pay as little as $5 per month (up to an annual maximum).
- Actemra — the Actemra Co-pay Card lets eligible commercially insured patients pay $0 per prescription (up to an annual maximum).
- Kineret — the Kineret Copay Program lets eligible commercially insured patients pay $0 per monthly prescription (up to an annual maximum).
(Copay-card terms and eligibility are set by the manufacturer and can change; open the medication’s page on NeedyMeds to confirm current details before relying on a specific amount. Copay cards are generally not available to patients with government insurance such as Medicaid or CHIP.)
If you’re uninsured or have limited income: Patient Assistance Programs
Patient Assistance Programs (PAPs) provide medication free or at low cost to families who meet income eligibility requirements:
- Amgen Safety Net Foundation — provides Enbrel at no cost to eligible uninsured and underinsured patients.
- Bristol-Myers Squibb Patient Assistance Foundation — covers Orencia for eligible patients.
- HealthWell Foundation Copay Program — an independent foundation that helps with copays and premiums for eligible patients (fund availability varies through the year).
Diagnosis-based assistance
Some foundations offer help based on the diagnosis rather than a specific drug. For juvenile arthritis families, one to know about is the Assistance Fund Juvenile Rheumatoid Arthritis Copay Assistance Program, which provides copay assistance specifically for patients diagnosed with juvenile rheumatoid arthritis. Like most foundation funds, it opens and closes during the year based on available funding.
For everyone: the free NeedyMeds Drug Discount Card
If you’re uninsured, underinsured, or a medication isn’t covered, the free NeedyMeds Drug Discount Card can be used at most pharmacies nationwide — no sign-up, no personal information, and no fees. Check current prices for your child’s medication at drugpricing.needymeds.org, or get the card on your phone with the free NeedyMeds Drug Discount Card app for iOS and Android.
You have options
A juvenile arthritis diagnosis is a lot for any family to take in — but juvenile arthritis medication costs don’t have to be the barrier that stops treatment, and the medications that manage it are within reach. Click any medication above to see the programs available for it, or search your child’s specific medication at needymeds.org.
This Juvenile Arthritis Awareness Month, please share this post with a family who might need it. No one should have to choose between their child’s health and their budget.
